(Q40403647)

English

Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age.

scientific article published on 27 November 2008

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Immunogenicity and safety of a tetanus toxoid, reduced diphtheria toxoid and three-component acellular pertussis vaccine in adults 19-64 years of age. (English)

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

tetanus vaccine

1 reference

based on heuristic

inferred from title

pertussis vaccine

1 reference

based on heuristic

inferred from title

author name string

Mark Blatter

1

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Leonard R Friedland

2

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Wayde M Weston

3

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Ping Li

4

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Barbara Howe

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

language of work or name

0 references

publication date

27 November 2008

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

27

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

765-772

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

The control of pertussis--2007 and beyond

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Infant pertussis: who was the source?

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Transmission of Bordetella pertussis to young infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Overview of pertussis: focus on epidemiology, sources of infection, and long term protection after infant vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

A "new age" in pertussis prevention new opportunities through adult vaccination

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Prevention of pertussis: Recommendations derived from the second Global Pertussis Initiative roundtable meeting

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Clinical experience of a tricomponent acellular pertussis vaccine combined with diphtheria and tetanus toxoids for primary vaccination in 22,505 infants

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Comparative analysis of two rates

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Efficacy of an acellular pertussis vaccine among adolescents and adults.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Extensive swelling reactions occurring after booster doses of diphtheria-tetanus-acellular pertussis vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Acellular pertussis vaccine booster combined with diphtheria and tetanus toxoids for adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Effects of lowering the aluminium content of a dTpa vaccine on its immunogenicity and reactogenicity when given as a booster to adolescents

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Safety of reduced-antigen-content tetanus-diphtheria-acellular pertussis vaccine in adolescents as a sixth consecutive dose of acellular pertussis-containing vaccine

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Primary vaccination of adults with reduced antigen-content diphtheria-tetanus-acellular pertussis or dTpa-inactivated poliovirus vaccines compared to diphtheria-tetanus-toxoid vaccines

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Pertussis immunisation in adolescents and adults--Bordetella pertussis epidemiology should guide vaccination recommendations

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Adult pertussis vaccination strategies and their impact on pertussis in the United States: evaluation of routine and targeted (cocoon) strategies.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Combined tetanus, diphtheria, and 5-component pertussis vaccine for use in adolescents and adults

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2008.11.028

7 January 2021

Identifiers

10.1016/J.VACCINE.2008.11.028

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

20 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40403647&oldid=2117319643"